Humana · Esa · US health-plan appeal rights

Esa denied as not FDA-approved for this use by Humana?

Q: How long do I have to appeal a Humana Esa denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Off-label use is widespread in medicine. If the literature and a recognised specialty-society guideline support the use, plans frequently approve on appeal — especially for cancer, cardiology, and rare disease.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-09

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Humana typically requires

Humana's specific coverage criteria for esa are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: Humana MA — ESRD anemia coverage (ESAs bundled in PPS)

The Humana angle on Esa

## Why Humana Denies ESAs as "Not FDA-Approved"

ESAs are FDA-approved medications, but coverage policies often restrict payment to specific FDA-approved indications — the labeled uses for which the agency reviewed safety and efficacy data. When an ESA is prescribed for a purpose that falls outside those labeled indications (sometimes called "off-label" use), Humana may deny the claim on the grounds that the use is not FDA-approved for that condition. This commonly arises when anemia has a cause not listed in the drug's approved labeling, such as certain non-myelosuppressive conditions.

## Why This Denial Is Appealable

Off-label use of an FDA-approved drug is standard medical practice and is expressly recognized in federal and state law as potentially reimbursable. Many state insurance codes and ERISA plan documents require coverage of off-label uses supported by peer-reviewed medical literature and recognized clinical compendia (such as the NCCN Drugs and Biologics Compendium or the American Hospital Formulary Service Drug Information). If the use is supported by such compendia or by substantial peer-reviewed evidence, the denial can be challenged.

## Federal Appeal Framework

Internal appeal (ERISA §503 / ACA §2719): Submit within the deadline in the denial letter. Cite the specific compendia or published clinical evidence supporting the use.
External review (ACA §2719): After exhausting internal appeals, escalate to an Independent Review Organization within approximately four months of the final internal denial — confirm the exact window in your documents.
State law layer: Many state prompt-pay and off-label-use statutes provide additional protections; check the laws of the state where the plan is issued.
Expedited option: Request expedited review if the patient's condition is urgent.

## Concrete Appeal Steps

1. Confirm with the prescriber the exact indication for which the ESA was ordered. 2. Verify whether that indication is listed in the FDA-approved prescribing label. 3. If it is off-label, identify the applicable clinical compendia entry or peer-reviewed publications supporting the use. 4. Obtain Humana's off-label-use or experimental/investigational policy from the provider portal. 5. Draft the appeal citing the compendia and/or literature, and submit with the documentation package below. 6. If denied internally, file for IRO external review.

## Documentation to Gather

Diagnosis confirmation: Chart notes and relevant diagnostics clearly establishing the condition being treated.
Prescriber letter: A detailed explanation of why this use of an ESA is medically necessary for this patient, citing the clinical evidence base (compendia citation, key publications by author/journal — not trial statistics).
Compendium excerpt: A printout of the relevant compendia entry (NCCN, AHFS, or similar) supporting the use, if available.
Clinical severity documentation: Chart entries describing the impact of the anemia on the patient's functional status and quality of life.
Prior therapy history: Any prior anemia treatment attempted, with dates and outcomes.

## Criteria-Mapping Structure

Build a two-column table. Left column: each requirement from Humana's off-label-use policy (copied verbatim). Right column: the specific chart entry or published source that satisfies each requirement. Attach the compendia pages and prescriber letter behind it.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Humana appeals

Other denial reasons for Humana Esa

denied as not medically necessary denied for failing step therapy denied as non-formulary denied for missing prior authorization denied as experimental or investigational

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-09. Editorial standards: denialhelp.com/authors.